Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization
2 other identifiers
interventional
250
1 country
1
Brief Summary
Cigarette smoking is the leading cause of death and disability in the United States. People with psychiatric disorders consume almost half (44.3%) of all cigarettes smoked in the U.S. and have life spans more than 20 years shorter than the general population. Effective quit smoking treatments for people with psychiatric disorders are sorely needed. When patients are hospitalized for a psychiatric disorder, they are not allowed to smoke. This enforced period of no smoking creates what professionals call "a teachable moment". It provides an excellent opportunity to discuss the prospect of staying quit once the individual leaves the hospital. In ongoing research, the investigators have developed and tested a Sustained Care quit smoking intervention for smokers engaged in a psychiatric hospitalization. The intervention includes: 1) a professionally-led, motivational counseling session to encourage quitting smoking and increase awareness about available quit smoking resources, 2) a referral to the Texas Tobacco Quitline for phone-based, quit smoking counseling, and 3) an offer of 8 weeks of nicotine patches after leaving the hospital. Findings from a recently completed clinical trial provide strong support for this Sustained Care intervention. Aims in the current project are to develop and test a tablet computer-based, motivational counseling intervention that does not require a trained professional counselor. The goal is to conduct a clinical trial to demonstrate the effectiveness of this tablet-based, Sustained Care intervention for smokers engaged in psychiatric hospitalization. As before, the same quit smoking resources (Quitline and nicotine patches) will be provided upon hospital discharge. If successful, next steps will involve plans to implement this quit smoking intervention in psychiatric hospitals throughout Texas, in order to reduce the burden caused by tobacco-related cancers among the citizens of Texas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 5, 2023
CompletedStudy Start
First participant enrolled
August 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedMay 8, 2024
May 1, 2024
2.7 years
December 21, 2022
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Smoking cessation
Binomial outcome of continued smoking abstinence vs. relapse modeled over time and controlling for gender and magnitude of initial nicotine dependence
1, 3, and 6 months after hospital discharge
Secondary Outcomes (1)
Number of quit attempts
First month following hospital discharge
Study Arms (2)
Tablet-based Sustained Care
EXPERIMENTALIntervention to support sustained smoking cessation.
Usual Care
NO INTERVENTIONStandard hospital care: : A brief (5-10 min.) tobacco education session from a hospital nurse, along with educational materials about quitting and a quitline brochure.
Interventions
A tablet-based motivational-interviewing intervention, tailored specifically to smokers with psychiatric disorders, to motivate the use of evidence-based tobacco treatment and cessation in cigarette smokers upon discharge from an inpatient psychiatric hospitalization. In addition, participants will receive standard hospital tobacco care (see Usual Care Arm).
Eligibility Criteria
You may qualify if:
- Male or female patients above the age of 18 capable of providing informed consent
- Current smoker (at least 5 cigarettes/day when not hospitalized)
- Willing and able to provide informed consent, attend all study visits, and comply with the protocol
You may not qualify if:
- Mini-Mental State Examination (MMSE) score \< 24
- Current diagnosis of dementia or other cognitive impairment that would limit study participation
- Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures
- Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification
- No access to or inability to communicate by phone, or no stable mailing address
- Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.)
- Medical contraindication to nicotine patch use
- Currently pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Texas at Austinlead
- Ascension Seton Shoal Creekcollaborator
- Cancer Prevention Research Institute of Texascollaborator
Study Sites (1)
Ascension Shoal Creek
Austin, Texas, 78731, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Brown, Ph.D.
The University of Texas at Austin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Professor
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 5, 2023
Study Start
August 10, 2023
Primary Completion
May 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share